Drugs / Mayne Glucagon
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00745186 | Aug → Oct 2007 | hypoglycemia | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mayne Glucagon | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00745186 ↗ |
| Known as | Mayne Glucagon for Injection | “The formulation, routes of administration, dosage regimen and indications of Mayne Glucagon for Injection are identical to those currently registered for the marketed product.” NCT00745186 ↗ |